Murayama Kenji, Nanami Tatsuki, Suzuki Takashi, Oshima Yoko, Yajima Satoshi, Nemoto Tetsuo, Shimada Hideaki
Department of Surgery, Toho University School of Medicine, 6-11-1 Omori-Nishi, Ota-ku, Tokyo, 143-8541, Japan.
Department of Clinical Oncology, Toho University Graduate School of Medicine, 6-11-1 Omori-nishi, Ota-ku, Tokyo, Japan.
Clin J Gastroenterol. 2017 Aug;10(4):357-360. doi: 10.1007/s12328-017-0749-9. Epub 2017 May 24.
We performed distal gastrectomy with D2 lymph node dissection, pathological stage was Stage IB (T2N0M0), in a 68-year-old male with gastric adenocarcinoma. We then monitored serum p53 antibody titers for 5 years and found it consistently decreased, without disease recurrence. Although the s-p53-Ab titer remained positive even after 2 years, it decreased to 16.5, 4.45, 2.66, 1.55, and 1.18 U/ml at 3 months, 7 months, 1 year, 2 years and 3 years after surgery, respectively. The s-p53-Ab titer finally converted from positive to negative at 31 months postoperatively without any sign of recurrence by computed tomography examination at 5 years after surgery. This case report shows that the changing pattern of s-p53-Ab titer after surgery may be useful to identify patients without recurrence. Further studies are required to gain a more precise understanding of the clinical impact of s-p53-Ab titer monitoring in gastric adenocarcinoma.
我们对一名68岁的胃腺癌男性患者进行了远端胃切除术及D2淋巴结清扫术,病理分期为IB期(T2N0M0)。随后我们对其血清p53抗体滴度进行了5年的监测,发现其持续下降,且无疾病复发。尽管s-p53-Ab滴度在2年后仍为阳性,但在术后3个月、7个月、1年、2年和3年时分别降至16.5、4.45、2.66、1.55和1.18 U/ml。术后31个月时,s-p53-Ab滴度最终由阳性转为阴性,术后5年的计算机断层扫描检查未发现任何复发迹象。本病例报告表明,术后s-p53-Ab滴度的变化模式可能有助于识别无复发的患者。需要进一步研究以更精确地了解s-p53-Ab滴度监测对胃腺癌的临床影响。